Compare YELP & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YELP | LMAT |
|---|---|---|
| Founded | 2004 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2012 | 2006 |
| Metric | YELP | LMAT |
|---|---|---|
| Price | $28.95 | $82.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | $32.00 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 1.1M | 194.6K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.96% |
| EPS Growth | ★ 37.30 | 27.40 |
| EPS | 2.25 | ★ 2.32 |
| Revenue | ★ $1,466,918,000.00 | $240,866,000.00 |
| Revenue This Year | $6.16 | $16.27 |
| Revenue Next Year | $3.80 | $8.61 |
| P/E Ratio | ★ $12.87 | $35.80 |
| Revenue Growth | 5.34 | ★ 13.07 |
| 52 Week Low | $27.29 | $71.42 |
| 52 Week High | $41.72 | $106.93 |
| Indicator | YELP | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 42.86 | 35.66 |
| Support Level | $28.41 | $81.92 |
| Resistance Level | $29.60 | $89.43 |
| Average True Range (ATR) | 0.68 | 2.76 |
| MACD | 0.09 | -0.49 |
| Stochastic Oscillator | 59.64 | 3.35 |
Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.